by editor | Aug 15, 2014 | Clinicians, Participants
New ASPREE hearing sub-study Two-thirds of older adults over the age of 70 years experience hearing loss associated with ageing. There is no known single cause and no known cure for this type of hearing loss, which can have a profound effect on a person’s...
by editor | Aug 15, 2014 | Participants
Crossing the Victoria/South Australia Border Above: The ASPREE Healthy Ageing Biobus, a mobile laboratory that brings research to regional and rural parts of Australia, crossed the border into SA this week. With around half of ASPREE participants living...
by editor | Aug 7, 2014 | Clinicians, Participants, Researchers
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people aged 50-65 against gastrointestinal cancer, but was unable to determine cancer benefits for those aged over 70. International researchers, who analysed...
by editor | Aug 1, 2014 | Clinicians, Participants
An update on study updates We’ve had a fantastic time meeting participants and guests at study updates this year and are pleased to shared a few photos from some of the events. ASPREE Executive Officer, Associate Professor Robyn Woods, gave all the...
by editor | May 30, 2014 | Participants
High quality data answers important questions Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
Recent Comments